In pancreatic and ovarian cancers, leptin–ObR signalling promotes extracellular matrix remodelling, migration, and invasion through upregulation of matrix metalloproteinase-13, an enzyme that breaks down the extracellular matrix, particularly collagen, and downstream effectors (110, 120). Here, LEPR is linked to ovarian carcinoma.